The US and Canada have healthcare, life science and medical device industries that are complex and interconnected.

On March 6, President Donald Trump instituted a 25 percent ad valorem rate of duty on goods imported from Canada under the International Emergency Economic Powers Act.[1] The tariffs will not be implemented on goods that comply with the United States-MexicoCanada Agreement until April 2.[2] In turn, Canada has announced a $155 billion tariff package on the US.[3]

Download the full Law360 article, "Mitigating Tariff Risks For Healthcare In US And Canada."



Contacts

Jeff Wurzburg
Jeff Wurzburg
Partner
Email
jeff.wurzburg@nortonrosefulbright.com
T: +1 210 270 9338
Vanessa Grant
Vanessa Grant
Senior Partner
Email
vanessa.grant@nortonrosefulbright.com
T: +1 416 216 4056

Practice areas:

Industry:

Recent publications

data center interior

Publication

Navigating regulatory challenges in data centres

Businesses investing in, financing or operating data centres face a complex matrix of laws and regulatory requirements.

Global | May 01, 2025

Tech sector
green-energy-concept

Publication

TMO4+ connection reform proposals receive stamp of approval

On 15 April 2025, Ofgem approved the National Energy System Operator’s (NESO) Target Model Option 4 (TMO4+) package of reforms.

Global | April 25, 2025

Energy, infrastructure and resources

Publication

Distress signals: Cooperation agreements or mergers to the rescue in times of crisis?

The current volatile and unpredictable economic climate creates challenges for businesses.

Global | April 23, 2025

Merger control
Site search

Subscribe and stay up to date with the latest legal news, information and events . . .

Register now